STANDARD INDUSTRIAL CLASSIFICATION 2834

Pharmaceutical Preparations

Documented enforcement actions, accounting mechanics, and penalty records for companies operating under SIC code 2834.

SECTOR ENFORCEMENT BENCHMARKS
  • 4 major corporate fraud cases are documented under SIC 2834: Pharmaceutical Preparations.
  • Cumulative financial overstatements in this industry sector reach $10.3B.
  • Total regulatory and criminal civil sanctions and penalties amount to $552.0M.
ENFORCEMENT CASES 4 SIC code 2834
TOTAL OVERSTATEMENT $10.3B Reported distortion
TOTAL PENALTIES $552.0M Sanctions & recoveries
JURISDICTIONS 4 Regulatory venues

ENFORCEMENT RECORDS (SIC 2834)

4 ACTIONS
Case Title Company / Issuer Jurisdiction Status Overstatement Penalties
Bristol-Myers Squibb: $2B Channel Stuffing with Wholesaler Incentives Bristol-Myers Squibb Company US Settled, neither admitted nor denied $2.0B $150.0M
Samsung BioLogics: 4.5 Trillion Won Acquisition Accounting Inflation Samsung BioLogics Co., Ltd. KR Adjudicated $3.8B $7.0M
Valeant Pharmaceuticals: Undisclosed Captive Pharmacy Philidor and Channel Stuffing Valeant Pharmaceuticals International, Inc. CA Settled, neither admitted nor denied $58.0M $45.0M
Kangmei Pharmaceutical: 30 Billion Yuan ($4.4B) Fabricated Cash Balances Kangmei Pharmaceutical Co., Ltd. CN Adjudicated $4.4B $350.0M